Scientists are fighting for their halted funds. Trust of Black communities may be harder to win back

ABC News
Original Story by ABC News
November 22, 2026
Scientists are fighting for their halted funds. Trust of Black communities may be harder to win back

A Pittsburgh Alzheimer’s study focusing on Black Americans was halted by NIH near its completion, wasting over $8 million and leaving participants without answers about potential brain health signals. The move, framed by officials as de-emphasizing “not science,” has sparked widespread concern about political bias and its impact on community trust and ongoing research into racial disparities in dementia. Researchers and participants fear long-term damage to trust in health institutions, complicating future engagement with Black communities. The episode, set against a broader pattern of funding stoppages, raises questions about the balance between policy priorities and scientific inquiry, with some lawsuits challenging the terminations and calls to restore commitments to participants. The path forward remains uncertain as institutions attempt to repair trust and determine how to proceed with prior study findings and samples.

Dive Deeper:

  • In Pittsburgh, a long-running study sought to understand why Black Americans are twice as likely as white peers to develop Alzheimer’s, involving memory tests, sleep and blood pressure tracking, and storytelling from participants in Hill and Homewood communities to address dementia risk and misconceptions.

  • The NIH abruptly terminated the Pittsburgh project in its fifth year, arguing the work was not science, despite rigorous community vetting and near-completion, a move that critics say wastes taxpayer money and betrays participant trust.

  • Similar terminations occurred nationwide, including Negar Fani’s five-year, $2.9 million project on how racial discrimination affects the brain, which was halted two years into the study with about 66 of 220 planned participants enrolled.

  • Several researchers, including lead Pittsburgh investigator Andrea Rosso and Ann Cohen of the Alzheimer’s Disease Research Center, joined lawsuits against NIH and HHS over these funding decisions and the handling of collected data and samples.

  • Participants and researchers warn that trust built with Black communities is eroded quickly when studies are halted midstream, complicating future recruitment and engagement for health disparities research.

  • Official statements cite shifting funds toward what they deem more rigorous science and express concern that DEI-oriented grants have not translated into better health outcomes, a stance that critics say discounts the value of inclusive, community-based research.

  • The broader implication is that halted studies leave unanswered questions about dementia risk and potential care, with funding cuts potentially stalling progress on understanding and addressing racial disparities in Alzheimer’s disease.

Latest News

Related Stories